About EPAX

EPAX AS is a world leading bulk supplier of ultra-pure, highly concentrated, marine-based Omega-3 EPA/DHA fatty acids. EPAX AS is a Norwegian company based in Aalesund with a sales and marketing office in Lysaker/Oslo.

EPAX products are individually formulated with varying EPA/DHA ratios and concentrations designed to target specific health concerns including cardiovascular, cognitive, mood and mind, eye, joint, pre- and postnatal health, and to support a healthy inflammation response. Click here to learn more about these health conditions.

Each EPAX condition-specific formula is backed by years of clinical research, testing and validation. EPAX products have been used in approximately 100 clinical studies. We are committed to delivering products that are safe, pure and of a consistently high quality. 

EPAX has a long history of marine oil production to draw on and we are dedicated to constantly endeavouring to improve the purity and quality, as well as the production and purification technology of our products.

EPAX is the industry leader in terms of product purity. We have very strict maximum limits for environmental pollutants as well as maximum limits for oxidation parameters.

 
 

Ownership

EPAX is a wholly-owned subsidiary of the Norwegian company Austevoll Seafood ASA, a global pelagic fishery specialist which operates in Chile, Peru and Norway, operating a fleet of fishing vessels with quotas.

EPAX is thus a fully vertically integrated company with access to crude fish oil of the best possible quality and the most suitable ratios of EPA/DHA.

Please visit www.auss.no for more information about Austevoll Seafood ASA.

 
 
EPAX News & Events

Trygg Pharma AS has acquired 100 percent of the shares in EPAX AS

AALESUND, Norway (Sept. 03, 2010) — Trygg Pharma AS, a company jointly owned by Aker BioMarine ASA, a Norwegian biotechnology company, and Lindsay Goldberg, a New York-based investment fund, has acquired 100 percent of the shares in EPAX AS from Austevoll Seafood ASA. EPAX AS is a world-leading supplier of concentrated, marine-derived omega-3 formulas that target specific health conditions.

Read press release



 
 

Epax Unveils Latest Study At Issfal 2010

Leading Omega-3 supplier, EPAX AS, will present results from studies related to the treatment and prevention of metabolic syndrome and Type 2 Diabetes at the ISSFAL1 conference which runs from 29th May – 2nd June in Maastricht, Netherlands.

Read press release

 
 

EPAX invites you to explore our enviromental stewardship policy


www.epax.com/ecovision

 
 
EPAX AS
PO Box 2047
NO-6028 Aalesund, Norway

Site Map        Disclaimer

© Copyright 2008  EPAX AS

Tlf: +47 70 13 59 60
Fax: +47 70 13 59 61
E-mail: epax@epax.com
sales@epax.com